Araris Biotech
Z├╝rich
About Araris Biotech
Araris Biotech is a biotechnology company that develops antibody-drug conjugates using a proprietary linker technology designed for efficient payload attachment without antibody engineering. The company's platform enables the creation of stable, homogenous ADCs with improved therapeutic efficacy and reduced side effects. The company focuses on advancing targeted cancer treatments by streamlining the ADC development process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $43.4M
- Funding stage: M&A
- Last round: Grant (Apr 2023)
- Website: ararisbiotech.com
- Phone: +41 56 310 45 98
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/araris-biotech-99626 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.